# Is NAD+ Legal? FDA, DEA and WADA Status | PepVault

Source: https://pepvault.app/peptides/nad/legal-status

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Peptides](https://pepvault.app/peptides) [NAD+](https://pepvault.app/peptides/nad) Legal status

Legal status in the United States

# Is NAD+ legal?

Read November 18, 2026 at FDA, DEA and WADA [Published by PepVault](https://pepvault.app/guides/how-we-research)

NAD+ has no FDA-approved product, is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 18, 2026.

## NAD+ at a glance

| Check | Status, read Nov 18, 2026 |
| --- | --- |
| [FDA approval](https://pepvault.app/peptides/nad/legal-status#ls-fda) | Not approved |
| [Compounding](https://pepvault.app/peptides/nad/legal-status#ls-compounding) | Under FDA evaluation (503A category 1) |
| [DEA schedule](https://pepvault.app/peptides/nad/legal-status#ls-dea) | Not controlled |
| [Sport (WADA)](https://pepvault.app/peptides/nad/legal-status#ls-wada) | Not named on the list |

## FDA approval

NAD+ has no FDA-approved drug: Drugs@FDA lists no application for it.

- [Drugs@FDA data (openFDA): applications listing “NICOTINAMIDE ADENINE DINUCLEOTIDE” as an active ingredient](https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name:%22NICOTINAMIDE%20ADENINE%20DINUCLEOTIDE%22), U.S. Food and Drug Administration. Read Nov 18, 2026.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Compounding

FDA lists nicotinamide adenine dinucleotide (NAD) in 503A category 1, bulk substances under evaluation, on its list updated May 14, 2026; it is not on the 503B bulks list.

The source: “Nicotinamide Adenine Dinucleotide (NAD)”

- [Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026)](https://www.fda.gov/media/94155/download), U.S. Food and Drug Administration. Read Nov 18, 2026.
- [503B Bulk Drug Substances List (content current as of May 16, 2024)](https://www.fda.gov/drugs/human-drug-compounding/503b-bulk-drug-substances-list), U.S. Food and Drug Administration. Read Nov 18, 2026.

## DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

- [21 CFR Part 1308, Schedules of Controlled Substances (eCFR, up to date as of November 16, 2026)](https://www.ecfr.gov/current/title-21/chapter-II/part-1308), Electronic Code of Federal Regulations. Read Nov 18, 2026.
- [Controlled Substances, Alphabetical Order (dated November 17, 2026)](https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf), Drug Enforcement Administration, Diversion Control Division. Read Nov 18, 2026.

## Sport (WADA)

The 2026 Prohibited List doesn’t name NAD+. Separately, its M2.2 bans intravenous infusions or injections of “more than a total of 100 mL per 12-hour period”, whatever they hold, outside hospital care.

- [World Anti-Doping Code International Standard, Prohibited List 2026 (in effect from January 1, 2026)](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf), World Anti-Doping Agency. Read Nov 18, 2026.

## How it is sold when it isn’t approved

FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.

The source: falsely labeled “for research purposes” or “not for human consumption.”

- [FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of October 1, 2026)](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss), U.S. Food and Drug Administration. Read Nov 18, 2026.

## What this means and doesn’t

This page reports what the agencies’ own pages said about NAD+ in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

## About NAD+

### NAD+

- [NAD+ in the library](https://pepvault.app/peptides/nad)
- [NAD+ dose guide](https://pepvault.app/lab/dosage/nad)

### Terms

- [Research use only (RUO)](https://pepvault.app/glossary/research-use-only)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Off-label use](https://pepvault.app/glossary/off-label)

## Questions

- ### Is NAD+ FDA approved?

  NAD+ has no FDA-approved drug: Drugs@FDA lists no application for it.
- ### Is NAD+ a controlled substance?

  It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
- ### Is NAD+ banned in sport?

  The 2026 Prohibited List doesn’t name NAD+. Separately, its M2.2 bans intravenous infusions or injections of “more than a total of 100 mL per 12-hour period”, whatever they hold, outside hospital care.
- ### What does FDA say about compounding NAD+?

  FDA lists nicotinamide adenine dinucleotide (NAD) in 503A category 1, bulk substances under evaluation, on its list updated May 14, 2026; it is not on the 503B bulks list.
- ### What does FDA say about the “research use only” label?

  FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.

## Read next

- [NAD+ in the library](https://pepvault.app/peptides/nad)
- [NAD+ dose guide](https://pepvault.app/lab/dosage/nad)
- [Research use only (RUO)](https://pepvault.app/glossary/research-use-only)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Off-label use](https://pepvault.app/glossary/off-label)
- [Every compound’s legal status](https://pepvault.app/peptide-legal-status)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## About NAD+

### NAD+

- [NAD+ in the library](https://pepvault.app/peptides/nad)
- [NAD+ dose guide](https://pepvault.app/lab/dosage/nad)

### Terms

- [Research use only (RUO)](https://pepvault.app/glossary/research-use-only)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Off-label use](https://pepvault.app/glossary/off-label)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=legal-status-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## NAD+

- [NAD+ in the library](https://pepvault.app/peptides/nad)
- [NAD+ dose guide](https://pepvault.app/lab/dosage/nad)

## Legal status

- [Every compound’s legal status](https://pepvault.app/peptide-legal-status)

## The glossary

- [Research use only (RUO)](https://pepvault.app/glossary/research-use-only)
- [Compounded drug](https://pepvault.app/glossary/compounded)
- [Off-label use](https://pepvault.app/glossary/off-label)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
